Applications are now open for The Advanced Genomics Collaboration 2023 Innovation Fund: supporting the translation and commercialisation of genomic innovations.
Please note, this will be a hybrid event. Registrants are welcome to join us in person, or online.
Genomics-focused Commercial Innovation Projects are invited to apply for up to $2 million in funding for up to two years from The Advanced Genomics Collaboration (TAGC).
Projects funded by this opportunity are required to:
- develop a commercial genomic based application, tool, diagnostic or service;
- create new job and student opportunities; and,
- ultimately be spun out into companies and/or result in products that are licensed/acquired by industry (not necessarily during the two year funding period).
To be eligible, applicants must be based at The University of Melbourne and MACH partner organisations, and include at least one University of Melbourne employee in the project team.
TAGC is a partnership between global leader in genomics, Illumina, and the University of Melbourne, made possible through significant assistance from Invest Victoria and the Victorian Government’s Department of Education and Training. The partnership is based inside the Melbourne Biomedical Precinct and uses genomics to create world-leading projects and businesses to improve health for everyone.
This opportunity fits within the University’s research innovation and commercialisation ecosystem,which includes the recently announced UoM Genesis Pre-Seed Fund and Tin Alley Ventures. Together, these funds and the University's wider innovation ecosystem provide the full research commercialisation pathway to support our community of world-leading researchers through the process of translating their early-stage research and new technologies into start-up companies.
Please make further enquiries about this opportunity via firstname.lastname@example.org.